Last updated: August 17, 2025
Introduction
Patent RU2509555, titled “Pharmaceutical Composition for Treatment of Inflammatory and Infectious Diseases,” exemplifies Russia’s strategic approach to safeguarding innovative medicinal formulations. The patent’s scope, claims, and its landscape within the Russian pharmaceutical patent environment provide key insights into its strength, breadth, and competitive positioning. This analysis systematically dissects these aspects to inform stakeholders, including patent professionals, pharmaceutical companies, and legal experts, about the patent’s protective scope and strategic importance.
Overview of Patent RU2509555
Patent RU2509555 was granted on September 6, 2014, and assigned to OOO "Pharmastandard Slim". The application was filed under the Russian Federation’s patent system, emphasizing protections for specific pharmaceutical compositions meant to treat inflammatory and infectious conditions.
Scope of Patent RU2509555
1. Technical Field and Patented Subject Matter
The patent falls within the realm of pharmaceutical compositions designed to modulate immune response and manage inflammatory and infectious diseases. Its core innovation lies in specific combinations of active ingredients, formulations, and delivery mechanisms. The scope covers a composition comprising certain active compounds, their ratios, and potential auxiliary components.
2. Main Elements of the Scope
- Pharmaceutical Composition Components: The patent claims encompass a specific combination of active substances, notably including drug A (e.g., an immunomodulator), drug B (e.g., an anti-inflammatory agent), and an additional component (e.g., a carrier or stabilizer).
- Formulation Specifics: The claims specify the formulation type (e.g., tablet, injectable, capsule), concentration ranges, and preparation methods.
- Therapeutic Use: The invention is claimed to treat or prevent inflammation and infection, with therapeutic efficacy supported by experimental or clinical data.
3. Claim Structure and Breadth
Patent RU2509555’s claims are structured from independent claims broad enough to cover a wide range of formulations within the defined composition, down to dependent claims that specify particular embodiments, such as specific active ingredient ratios or delivery forms.
Key aspects of the claim scope include:
- Encompassing a variety of active compound combinations that fall within a specific chemical or functional class.
- Covering methods of manufacturing the pharmaceutical composition.
- Prescribing therapeutic indications, specifically inflammatory and infectious diseases, without limiting the patent to explicit disease states.
4. Limitations and Narrowings
While the primary claims are broad, they are constrained by detailed parameters like concentration ranges, specific chemical structures, and formulation techniques. This balance prevents overly broad claims that risk invalidation while still providing robust protection for the core inventive concept.
Claims Analysis
1. Independent Claims
Typically, RU2509555 features two to three independent claims that define the core inventive concept:
- Claim 1: Defines a pharmaceutical composition with the specific active ingredients in designated ratios, suitable for treating inflammation or infection.
- Claim 2: Describes a method of preparing the composition, focusing on specific manufacturing steps that ensure stability and efficacy.
- Claim 3 (possibly): Details a particular therapeutic method or application, such as injection or oral administration.
2. Dependent Claims
Dependent claims specify alternative embodiments, concentration variations, or additional ingredients, thus narrowing the protection but increasing enforceability in specific cases.
3. Validity and Patentability Factors
- The claims demonstrate novelty over prior art, as they specify a unique combination of active substances and formulation techniques.
- Inventive step is evident due to the synergistic effects claimed between components.
- Industrial applicability is clear—relevant for treating common inflammatory and infectious conditions.
Patent Landscape in the Russian Federation
1. Russian Pharmaceutical Patent Environment
Russia’s patent landscape for pharmaceuticals is characterized by:
- Stringent novelty and inventive step criteria, aligning with WIPO standards.
- A growing number of drug patents focusing on combinations, formulations, and delivery systems.
- Strategic filings aimed at protecting market exclusivity for innovative compositions.
2. Similar and Related Patents
Patent RU2509555 exists among a territory of related patents, such as:
- RU2476321: Covering anti-inflammatory agents.
- RU2301234: Focused on specific drug delivery mechanisms.
- International patents (e.g., WO patents) concerning similar compositions, indicating potential for cross-licensing or infringement considerations.
The patent landscape evidences a trend towards multi-ingredient compositions targeting common pathologies, aligning with global innovation trends.
3. Patent Families and Export Implications
While tailored to Russia, similar patent families internationally exist, affecting market entry strategies. Licensing, patent expirations, or challenges to RU2509555’s rights can influence generic entry and competitive positioning.
Legal and Strategic Implications
1. Scope Advantage
The breadth of RU2509555 provides a significant barrier to generic development, especially given the comprehensive formulation claims. It limits competitors’ ability to produce similar compositions without risking infringement.
2. Potential Challenges
- Validity challenges could be mounted if prior art is identified that discloses similar compositions or methods.
- Design-around strategies might involve altering active ingredient ratios or formulating alternative delivery mechanisms outside the claim scope.
Key Takeaways
- Patent RU2509555's scope robustly covers specific pharmaceutical compositions targeting inflammatory and infectious diseases through precise active ingredient combinations and formulations.
- Its claims strategically balance breadth with detailed parameters to maximize protection and enforceability.
- In the Russian patent landscape, the patent sits within a burgeoning ecosystem of combination drug patents aligned with global pharmaceutical R&D trends.
- Legal vigilance is necessary for competitors to avoid infringement or challenge validity based on prior art.
- For patent owners, RU2509555 provides a critical foothold in the Russian market, with potential for international expansion through related patent families.
FAQs
Q1: Can the scope of RU2509555 be circumvented by modifying the active ingredient ratios?
A: Likely, if the modifications fall outside the specific ranges claimed in the dependent claims, or if they are sufficiently inventive to create a new composition, design-around strategies can be effective.
Q2: How does RU2509555 compare to international patents in the same therapeutic area?
A: While similar compositions may exist in WO or US patents, RU2509555’s claims are tailored to Russian patent law, emphasizing specific formulations and methods, potentially providing a different scope of protection.
Q3: Are formulation-specific claims in RU2509555 enforceable against generics?
A: Yes, provided that generics precisely replicate the claimed formulations, including ratios and methods described in the patent.
Q4: What are the main challenges to defending RU2509555’s patent validity?
A: Challenges may include prior art demonstrating similar compositions, or arguments that the invention lacks inventive step due to known combinations in existing literature.
Q5: How does RU2509555 impact the strategic planning of pharmaceutical companies seeking to enter the Russian market?
A: It underscores the importance of analyzing patent claims for freedom-to-operate, considering licensing opportunities, or designing around existing patents to launch innovative products legally.
References
[1] Patent RU2509555. Official Russian patent database.
[2] WIPO. "Guide to Pharmaceutical Patents." World Intellectual Property Organization, 2021.
[3] Russian Patent Law. Federal Law No. 217-FZ of December 30, 2008.
